BBIO
BridgeBio Pharma, Inc.
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $946M | +127.4% |
| Gross profit | $892M | — |
| Operating income | −$364M | — |
| Net income | −$566M | — |
| EPS | −$3.04 | — |
| Free cash flow | −$370M | — |
BridgeBio Pharma, Inc.
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $946M | +127.4% |
| Gross profit | $892M | — |
| Operating income | −$364M | — |
| Net income | −$566M | — |
| EPS | −$3.04 | — |
| Free cash flow | −$370M | — |